| Patents for A61P 13 - Drugs for disorders of the urinary system (56,135) |
|---|
| 06/23/2011 | US20110152171 Histamine binding protein |
| 06/23/2011 | US20110152169 Sparc anti-inflammatory activity and uses thereof |
| 06/23/2011 | US20110152168 Antiadhesive carbohydrates |
| 06/23/2011 | US20110151579 Secreted Epithelial Stromal-1 Molecules and Uses Thereof |
| 06/23/2011 | US20110150980 Cgrp analog |
| 06/23/2011 | US20110150937 Extended release compositions comprising tolterodine |
| 06/23/2011 | US20110150891 Methods of Treating Interstitial Cystitis |
| 06/23/2011 | US20110150879 Specific depletion of cd4+ t cells |
| 06/23/2011 | US20110150858 therapeutic agent for a lower urinary tract disease and an agent for improving a lower urinary tract symptom |
| 06/23/2011 | US20110150830 Covalent conjugates between endoperoxides and transferrin and lactoferrin receptor-binding agents |
| 06/23/2011 | US20110145970 Detection and use of low molecular-weight modulators of the cold-menthol receptor trpm8 |
| 06/23/2011 | CA2784093A1 Wise binding agents and epitopes |
| 06/23/2011 | CA2781725A1 Methods of treating interstitial cystitis |
| 06/22/2011 | EP2336301A1 Post-partum mammalian placenta, its use and placental stem cells therefrom |
| 06/22/2011 | EP2336300A1 Post-partum mammalian placenta, its use and placental stem cells therefrom |
| 06/22/2011 | EP2336299A1 Post-partum mammalian placenta, its use and placental stem cells therefrom |
| 06/22/2011 | EP2336297A2 Gynogenetic or androgenetic production of pluripotent cells and cell lines, and use thereof to produce differentiated cells and tissues |
| 06/22/2011 | EP2336185A1 Anti- alpha v beta 6 antibodies |
| 06/22/2011 | EP2336167A1 MHC molecule constructs and their uses for diagnosis and therapy |
| 06/22/2011 | EP2336124A1 Stable hydrate of a muscarinic receptor antagonist |
| 06/22/2011 | EP2336111A1 Heterocyclic inhibitors of p38 |
| 06/22/2011 | EP2336109A1 Novel pyrrolinone derivative and medicinal composition containing same |
| 06/22/2011 | EP2336105A1 Nitrogen-containing heterocyclic compound and use of same |
| 06/22/2011 | EP2335709A1 Insulin resistance improving agent |
| 06/22/2011 | EP2334303A1 Tyrosine kinase receptor tyro3 as a therapeutic target in the treatment of cancer |
| 06/22/2011 | EP2334292A1 Method of determining a phosphorus binder dosage for a dialysis patient |
| 06/22/2011 | CN1903364B Medicine composition containing inhibitor of angiotonase and phenoxy acid compounds |
| 06/22/2011 | CN1809570B [1,2,4 ]triazolo [1,5-a]pyrimidin-2-ylurea derivative and use thereof |
| 06/22/2011 | CN1733273B Process for preparing the sanjin pharmaceutical agent |
| 06/22/2011 | CN102105453A Therapeutic agent for chronic renal failure |
| 06/22/2011 | CN102102066A Cortex acanthopanacis yellow rice wine and production technology thereof |
| 06/22/2011 | CN102101893A Method for enriching and purifying aloe polysaccharides in aloe |
| 06/22/2011 | CN102101881A Preparation and application of pidotimod potassium salt |
| 06/22/2011 | CN102100904A Reduced glutathione percutaneous absorption preparation and preparation method thereof |
| 06/22/2011 | CN102100898A Preparation technology of new integrative formulation of pinellia decoction for purging stomach fire and production method thereof |
| 06/22/2011 | CN102100891A Preparation technology and production method of new integrative formulation of true warrior decoction |
| 06/22/2011 | CN102100888A Preparation technology and production method of new integrative formulation of major green-blue dragon decoction |
| 06/22/2011 | CN102100886A Technology and method for preparing novel combined formulation of relieving-edema decoction |
| 06/22/2011 | CN102100885A Preparation technology and production method of integrated minor bupleurum decoction novel dosage form |
| 06/22/2011 | CN102100858A Chinese medicinal preparation for treating early diabetic nephropathy and preparation method thereof |
| 06/22/2011 | CN102100845A Medicament for treating deficiency of kidney, frequent micturition, urgent urination and prostatitis |
| 06/22/2011 | CN102100834A Chinese medicine composition for treating diabetic nephropathy (DN) as well as preparation and preparation method thereof |
| 06/22/2011 | CN102100813A Preparation technology of new integrative formulation of poria five powder and production method thereof |
| 06/22/2011 | CN102100756A Preparation technology of integrated rhubarb and aconite decoction novel dosage form |
| 06/22/2011 | CN102100755A Preparation technology of integrated ephedra, aconite and asarum decoction novel dosage form |
| 06/22/2011 | CN102100742A Water-solubility extract of root of red-rooted salvia, preparation method thereof and application thereof |
| 06/22/2011 | CN102100728A Technology and method for preparing novel combined formulation of jade-screen powder |
| 06/22/2011 | CN102100711A Application of pseudoginseng root total saponins and preparations thereof in adjuvant treatment of 'systemic inflammatory response syndrome' |
| 06/22/2011 | CN102100664A Injection containing pidotimod potassium salt and preparation method thereof |
| 06/22/2011 | CN101810796B Medicament for treating nephritic syndromes |
| 06/22/2011 | CN101703746B Medicinal composition for treating prostatitis and preparation method thereof |
| 06/22/2011 | CN101671380B 5-alpha reductase inhibitor-smartweed diffractive ring lignan glucoside B and preparation method thereof |
| 06/22/2011 | CN101671379B 5-alpha reductase inhibitor-smartweed diffractive ring lignan glucoside A and preparation method thereof |
| 06/22/2011 | CN101637559B Instant oral liquid for kidney stone |
| 06/22/2011 | CN101633645B N3 alkylated benzimidazole derivatives as mek inhibitors |
| 06/22/2011 | CN101057921B Traditional Chinese medicine capsule for treating prostatic hyperplasia |
| 06/22/2011 | CN101001857B 2-(pyridin-2-ylamino)-pyrido [2,3-d]pyrimidin-7-ones |
| 06/21/2011 | USRE42477 Carboxylic acid derivatives, their preparation and use |
| 06/21/2011 | US7964646 3,4-DI-substituted cyclobutene-1,2-diones as CXC-chemokine receptor ligands |
| 06/21/2011 | US7964187 Sensitization of chemotherapeutic agent resistant neoplastic cells with a virus |
| 06/21/2011 | CA2486336C Pentafluorosulfanylbenzoylguanidines, process for their preparation, their use as medicament or diagnostic aid, and medicament comprising them |
| 06/21/2011 | CA2474192C Nicotinamide derivates useful as p38 inhibitors |
| 06/21/2011 | CA2370775C Use of a serenoa repens extract for the production of a medicament to treat prostate cancer |
| 06/21/2011 | CA2359115C Acyl derivatives which treat vla-4 related disorders |
| 06/16/2011 | WO2011072275A2 Agents and methods for treating ischemic and other diseases |
| 06/16/2011 | WO2011072216A2 Treatment methods utilizing stem cell mobilizers and immunosuppressive agents |
| 06/16/2011 | WO2011071095A1 Benzamide compound |
| 06/16/2011 | WO2011070974A1 Cell preparation for treating prostatic cancer comprising adipose tissue-derived mesenchymal stem cells |
| 06/16/2011 | WO2011070049A1 Endothelin inhibitors for the treatment of rapidly progressive glomerulonephritis |
| 06/16/2011 | WO2011070032A1 Arenicin-3 for use in the treatment of urinary tract infections |
| 06/16/2011 | WO2011047770A3 Pyrazolopyrimidine derivatives |
| 06/16/2011 | WO2010097243A3 Process for forming solid oral dosage forms of solifenacin and its pharmaceutically acceptable salts |
| 06/16/2011 | US20110144309 Manipulation of Cytokine Levels Using CD83 Gene Products |
| 06/16/2011 | US20110144197 Alcanoic acid amides substituted by saturated o-heterocycles |
| 06/16/2011 | US20110144164 Pyridone derivatives as NK3 antagonists |
| 06/16/2011 | US20110144159 Ether benzylidene piperidine aryl carboxamide compounds useful as faah inhibitors |
| 06/16/2011 | US20110144153 Amide compound |
| 06/16/2011 | US20110144140 Pyridinyl-pyrimidine derivatives useful as potassium channel modulating agents |
| 06/16/2011 | US20110144138 Substituted pyrimido isoquinoline derivatives |
| 06/16/2011 | US20110144132 Substituted pyrimidin-4-one derivatives |
| 06/16/2011 | US20110144123 Thiazoles and Oxazoles Useful as Modulators of ATP-Binding Cassette Transporters |
| 06/16/2011 | US20110144074 Caspase inhibitors and uses thereof |
| 06/16/2011 | US20110144057 Antagonists of the vanilloid receptor subtype 1 (vr1) and use thereof |
| 06/16/2011 | US20110144051 Compositions and methods for treatment of mitochondrial diseases |
| 06/16/2011 | US20110144007 Glucose-dependent insulinotropic polypeptide analogues |
| 06/16/2011 | US20110144002 Use of AMPs for Treatment of UTI/Cystitis |
| 06/16/2011 | US20110143995 Novel anti-allergic agents |
| 06/16/2011 | US20110143991 Peptides for Activation and Inhibition of Delta-PKC |
| 06/16/2011 | US20110142948 Nanoparticle Carrier Systems based on Human Serum Albumin for Photodynamic Therapy |
| 06/16/2011 | US20110142886 Pegylated polyplexes for polynucleotide delivery |
| 06/16/2011 | US20110142805 Method of renal repair and regeneration and the treatment of diabetic nephropathy |
| 06/16/2011 | US20110139654 Oxadiazole derivatives for the treatment of diabetes |
| 06/16/2011 | US20110138888 Treatment of obesity |
| 06/16/2011 | CA2783537A1 Benzamide compound |
| 06/16/2011 | CA2781888A1 Agents and methods for treating ischemic and other diseases |
| 06/15/2011 | EP2333052A1 Desaturase genes and uses thereof |
| 06/15/2011 | EP2332953A1 Substituted amine derivative and medicinal composition comprising same as the active ingredient |
| 06/15/2011 | EP2332924A1 Pyrimidine derivates, medicaments comprising them, their use and process of their preparation |
| 06/15/2011 | EP2332922A1 N-substituted azoles and their use as MEK-1 and/or ERK-2 modulators |
| 06/15/2011 | EP2332579A2 Antibodies that bind human interleukin-18 and methods of making and using |